# AbbVie Inc. (ABBV) — Q4-2017 Earnings Results

**Report date:** 2018-01-26 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2017

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Up 13.77%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.48 | N/A | +2.08% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Confident

Management expressed confidence in the company's ongoing performance. They highlighted strong results in their core products and a commitment to future growth.

**Key quotes:**

> The company continues to show strong performance in key therapeutic areas.

> We are committed to delivering value to our shareholders.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

AbbVie's earnings report showed a positive surprise in EPS, which likely contributed to the stock's significant rise of 13.77%. The management's confident tone and focus on strong performance in key areas suggest that the company is on a solid path moving forward. However, the lack of revenue data and guidance may leave some investors cautious.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2017_